Pt.1. Public policy issues -- The HEW task force on prescription drugs: an insider's perspective -- Health policy initiatives and the utility of economic research -- The technology trust fund: paying for medical technology -- Medicaid drug cost containment: an economic perspective -- Public policy and drug costs: legitimate and bastard options -- Pt.2. Interventions and controls -- The Iowa Pharmacy Capitation Experiment: economic incentives and provider performance -- Incorporating severity-of-illness measures into retrospective claims-based cost-effective analyses. Initial impact of a Medicaid prior authorization program for NSAID prescriptions -- Effect of a medication utilization review on Medicaid health care expenditures: a case study of patients with noninsulin-dependent diabetes mellitus -- Impact of an open formulary system on the utilization of medical services -- Pt.3. Analytical approaches -- A research framework for economic epidemiology -- Socioeconomic evaluation and the health care industry -- Assessment of a contingent valuation technique with utility estimation models. Using repeated measures designs to evaluate interventions: a multivariate approach -- Pharmacoeconomic analysis of oral treatments for onychomycosis: a Canadian study -- QALYs in health outcomes research: representation of real preferences or another numerical abstraction? -- Pt.4. Prices and pricing -- Price control policies in the pharmaceutical industry: a selection of case studies -- Why Medicaid pays more: a comparison of private payment and Medicaid prescription prices, quantities, product mix, and dosage forms. Physicians' perceptions of prescription drug prices: their accuracy and effect on the prescribing decision -- Does drug insurance influence physician prescribing? -- An exploratory study of physician perceptions of drug price information and a prescription price newsletter -- Toward an understanding of pharmaceutical pricing strategies through the use of single game theoretic models -- Pricing and perspectives -- Pt.5. Economics and marketing -- Content analysis of pharmacoeconomic appeals in pharmaceutical drug product advertisement -- Economics of prescription drug advertising. The role of health economics in marketing new pharmaceuticals worldwide -- The benefits of pharmaceutical promotion: an economic and health perspective -- Pt.6. Economics of noncompliance -- The financial implications of initial noncompliance: an investigation of unclaimed prescriptions in community pharmacies -- Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate -- Pt.7. Effects on pharmacy -- Managed care and its effects on pharmacy services. Analysis of the impact of third-party prescription programs on community pharmacy -- Third-party associated cost-shift pricing in Georgia pharmacies -- Pharmacy participation in third-party contracts: decision making through economic and financial analysis.
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.